Beta Bionics, Inc. (BBNX) vs CeriBell, Inc. (CBLL)
A side-by-side comparison of Beta Bionics, Inc. and CeriBell, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BBNX
Beta Bionics, Inc.
$18.95HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CBLL
CeriBell, Inc.
$24.86HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BBNX vs CBLL
growth of $100 · dividends reinvested · last 2yBBNX -19.8% (-10.4%/yr)CBLL +4.5% (+2.2%/yr)CBLL compounded faster over this window
BBNX CBLL
BBNX vs CBLL: by the numbers
- •CBLL is the larger company ($943M vs $853M market cap).
- •Both run net losses; BBNX's is the smaller (-61.32% vs -64.73% net margin).
Metrics side by side
Valuation
| Metric | BBNX | CBLL |
|---|---|---|
| P/S ratio | 7.16 | 9.25 |
| P/B ratio | 3.33 | 7.35 |
Profitability
| Metric | BBNX | CBLL |
|---|---|---|
| Gross margin | 58.31% | 88.90% |
| Operating margin | -69.75% | -68.62% |
| Net margin | -61.32% | -64.73% |
| ROE | -28.46% | -51.43% |
| ROIC | -31.17% | -46.54% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.